About Astellas:
At Astellas we are a progressive health partner, delivering value and outcomes where needed.
We pursue innovative science, focussing initially on the areas of greatest potential and then developing solutions where patient need is high, often in rare or under-served disease areas and in life-threatening or life-limiting diseases and conditions.
We work directly with patients, doctors and health care professionals on the front line to ensure patient and clinical needs are guiding our development activities at every stage.
Our global vision for Patient Centricity is to support the development of innovative health solutions through a deep understanding of the patient experience. At Astellas, Patient Centricity isn’t a buzzword - it’s a guiding principle for action. We believe all staff have a role to play in creating a patient-centric culture and integrating an awareness of the patient into our everyday working practices, regardless of our role, team or division.
We work closely with regulatory authorities and payers to find new ways to ensure access to new therapies. We deliver the latest insights and real-world evidence to inform the best decisions for patients and their care-givers, to ensure the medicines we develop continue to provide meaningful outcomes.
Beyond medicines, we support our stakeholder communities to drive initiatives that improve awareness, education, access and ultimately standards of care.
The Opportunity:
As the Lead, Global Market Access and Pricing, Oncology, you will be responsible for the worldwide market access and pricing strategy for the product. You are the key interface between the GAVP team and all cross-functional partners, co-creation markets and beyond. You will have the final responsibility for the overall Market Access and Pricing Strategy – development, roll out and implementation, including LCM, across all co-creation markets and across the wider organization.
The Global Market Access Lead Oncology is responsible for bringing together complex payer requirements into a life cycle payer value proposition and tailoring Market Access & pricing strategies to optimize asset value and support the achievement of the Global Brand Score Card.
The role will report into the Head of Global Market Access Strategic Brands and will work closely with other key cross functional partners across the region.
Hybrid Working:
At Astellas we recognise the importance of balancing your work and home life. This role offers a remote working solution so you can optimize the most productive work environment for you to succeed and deliver.
Key Activities:
- Represent Global Market Access &VAST perspective on payer needs as a core member of the Asset Maximization Team and Global Co-creation Team and impact Commercialization and evidence generation strategy in alignment with AMT co-leads to optimize brand value under consideration of reimbursement & pricing requirements and dynamics.
- Lead the development and implementation of innovative pricing and reimbursement strategies using value-based methodologies that both capture optimal product value and support commercial strategy/product positioning for new indications.
- Develop global value story and global value dossier based on insights collated, identify areas needing Medical Affairs, Value Evidence, Clinical Development and Statistics input and seek analyses and evidence generation accordingly.
- Define the payer value requirements for the evidence generation plan throughout the lifecycle of the product, identify areas needing MA & VE input and execution in evidence generation plans and establish alignment with critical functions such as Regulatory, Clinical Development, Stats team and the co-creation and sub-co-creation Markets and endorsement by senior leadership.
- Work collaboratively with MA/VE and Commercial and Development Leads at Global, Area and Affiliate level to deliver integrated Evidence Generation Plan (iEGP), Brand Market Access Strategic Plan, ensuring it is embedded within the integrated Global Brand Plan, Core Medical Plans and Global & regional development plans, and that customer-relevant Global Brand Value Plans are developed and delivered.
- Lead the Value Access Strategy Team (VAST) and represent GMAx and VAST on the Asset Maximization Team (AMT) and Global Co-creation team (GCT).
Essential Knowledge & Experience:
- Proven experience in a global market access position within a multinational pharmaceutical organization.
- Deep knowledge/scientific background on the assigned therapy area – lung cancer is highly preferred.
- Experience across Market Access, Reimbursement or HEOR experience in the pharmaceutical industry with a proven track record of strategy development and execution.
- Experience in Health Outcomes, Access and pricing, marketing, and finance.
- Leadership skills and demonstrated ability to work effectively / influence without authority throughout the organization and on a global basis.
- Strong written and verbal communication in English.
Preferred Experience:
- Strong interpersonal, communication & collaboration skills working cross-functionally within matrix structures.
Education:
- Post-graduate qualification such as MBA and/or MSc or equivalent.
Additional information:
- This is a full-time, permanent position.
- The role is based out of Addlestone, UK. Can be based out of the Netherlands or the Nordics as well.
- This position follows our hybrid working model. Role requires a blend of home and a minimum of 1 day per quarter in our office. Flexibility may be required in line with business needs.
What We Offer:
- A challenging and diversified job in an international setting.
- Opportunity and support for continuous development.
- Inspiring work climate.
We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, colour, religion, sex, national origin, disability status, protected veteran status, or any other characteristic protected by law.
#LI-Addlestone
#LI-Hybrid
#LI-EN1